| |
| |
|
| Insider
Information: |
Malik Rajesh |
| Relationship: |
|
| City: |
Research Triangle Park |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
161,787 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$697,302 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
161,787 |
|
|
| Total
Value |
$697,302 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.3
|
| Percentage
Gain/Loss : |
0.0%
|
 -76.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
G1 Therapeutics Inc |
GTHX |
|
2024-05-13 |
161,787 |
2018-01-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-01-16 |
4 |
AS |
$22.96 |
$86,693 |
D/D |
(3,776) |
0 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-01-16 |
4 |
OE |
$0.30 |
$1,133 |
D/D |
3,776 |
3,776 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-02-15 |
4 |
AS |
$20.00 |
$75,520 |
D/D |
(3,776) |
0 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-02-15 |
4 |
OE |
$0.30 |
$1,213 |
D/D |
3,776 |
3,776 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-03-08 |
4 |
OE |
$0.39 |
$1,638 |
D/D |
4,200 |
4,200 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-03-15 |
4 |
AS |
$38.18 |
$144,151 |
D/D |
(3,776) |
4,200 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-03-15 |
4 |
OE |
$0.39 |
$3,348 |
D/D |
3,776 |
7,976 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-04-16 |
4 |
AS |
$35.95 |
$136,135 |
D/D |
(3,776) |
4,200 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-04-16 |
4 |
OE |
$4.17 |
$15,746 |
D/D |
3,776 |
7,976 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-05-15 |
4 |
OE |
$4.17 |
$15,746 |
D/D |
3,776 |
7,976 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-05-15 |
4 |
AS |
$46.29 |
$174,821 |
D/D |
(3,776) |
4,200 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-06-08 |
4 |
OE |
$0.39 |
$1,638 |
D/D |
4,200 |
8,400 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-06-15 |
4 |
AS |
$44.31 |
$167,326 |
D/D |
(3,776) |
8,400 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-06-15 |
4 |
OE |
$4.17 |
$15,746 |
D/D |
3,776 |
12,176 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-07-16 |
4 |
AS |
$41.91 |
$159,248 |
D/D |
(3,776) |
8,400 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-07-16 |
4 |
OE |
$4.17 |
$15,746 |
D/D |
3,776 |
12,176 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-08-15 |
4 |
AS |
$55.38 |
$211,023 |
D/D |
(3,776) |
8,400 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-08-15 |
4 |
OE |
$4.17 |
$15,746 |
D/D |
3,776 |
12,176 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-09-17 |
4 |
AS |
$65.78 |
$249,502 |
D/D |
(3,776) |
8,400 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-09-17 |
4 |
OE |
$4.17 |
$15,746 |
D/D |
3,776 |
12,176 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-10-15 |
4 |
AS |
$40.80 |
$157,497 |
D/D |
(3,776) |
8,400 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-10-15 |
4 |
OE |
$0.39 |
$18,203 |
D/D |
10,076 |
14,700 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-11-15 |
4 |
AS |
$39.71 |
$150,105 |
D/D |
(3,776) |
14,700 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-11-15 |
4 |
OE |
$4.17 |
$15,746 |
D/D |
3,776 |
18,476 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-12-17 |
4 |
AS |
$30.00 |
$113,280 |
D/D |
(3,776) |
14,700 |
0 |
- |
|
62 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
